Interleukin- 2 production during murine infection by Leishmania mexicana amazonensis

Interleukin- 2 production during murine infection by Leishmania mexicana amazonensis

Highly susceptible BALB/c mice, resistant C57B1/6 and their F1 progeny (BDF1) were infected subcutaneously in the foot pad with Leishmania mexicana amazonenesis. At various times after infection, spleen or draining popliteal lymph node cells were assayed for their capacity to generate Interleukin-2...

Full description

Bibliographic Details
Main Authors:	Manoel Barral-Netto, Silene B. Roters, Aldina Barral
Format:	Article
Language:	English
Published:	Fundação Oswaldo Cruz (FIOCRUZ) 1986-03-01
Series:	Memorias do Instituto Oswaldo Cruz
Subjects:	cutaneous leishmaniasis Interleukin-2 Leishmania (immunology) murine leishmaniasis lymphokines
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761986000100005

Similar Items

In vitro effects of lapachol and β-lapachone against Leishmania amazonensis
by: Á.C.F.H. Ramos-Milaré, et al.
Published: (2023-05-01)

Experimental infection of Lutzomyia longipalpis fed on a patient with cutaneous leishmaniasis due to Leishmania mexicana amazonensis
by: Leonidas M. Deane, et al.
Published: (1986-03-01)

Atividade leishmanicida de extrato hidroalcoólico de própolis brasileira em Leishmania amazonensis
by: Suelen Santos da Silva, et al.
Published: (2015-12-01)

Leishmania braziliensis: partial control of experimental infection by interleukin-12 p40 deficient mice
by: Sebastião Martins de Souza-Neto, et al.
Published: (2004-05-01)

The role of complement in the early phase of Leishmania (Leishmania) amazonensis infection in BALB/c mice
by: M.D. Laurenti, et al.
Published: (2004-03-01)

Analysis of the Antigenic and Prophylactic Properties of the Leishmania Translation Initiation Factors eIF2 and eIF2B in Natural and Experimental Leishmaniasis
by: Esther Garde, et al.
Published: (2018-04-01)

Cutaneous leishmaniasis in cats (Felis domesticus) caused by Leishmania (Leishmania) venezuelensis
by: Rafael Bonfante Garrido, et al.
Published: (2010-07-01)

Leishmania donovani Nucleoside Hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection
by: Dirlei eNico, et al.
Published: (2014-06-01)

IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis
by: Rodrigo Saar Gomes, et al.
Published: (2017-07-01)

Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB/c mice against infection
by: Herbert Leonel de Matos Guedes, et al.
Published: (2014-09-01)

Leishmania Parasites Drive PD-L1 Expression in Mice and Human Neutrophils With Suppressor Capacity
by: Alessandra M. da Fonseca-Martins, et al.
Published: (2021-06-01)

Complex cutaneous infection by Leishmania mexicana treated with miltefosine
by: Rachel L. Sadowsky, BA, et al.
Published: (2022-11-01)

Efficacy of the 7-chloro-4-(3-hydroxy-benzilidenehydrazo)quinoline derivative against infection caused by Leishmania amazonensis
by: Luciana Maria Ribeiro Antinarelli, et al.
Published: (2020-06-01)

Distinct ultrastructural aspects in different biopsies of a single patient with diffuse cutaneous leishmaniasis
by: Achilea Lisboa Bittencourt, et al.
Published: (1990-03-01)

Leishmania Exosomes/Extracellular Vesicles Containing GP63 Are Essential for Enhance Cutaneous Leishmaniasis Development Upon Co-Inoculation of Leishmania amazonensis and Its Exosomes
by: Alonso da Silva Lira Filho, et al.
Published: (2022-02-01)

Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel
by: Michal Solomon, et al.
Published: (2019-04-01)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
by: Ma. Florencia Peralta, et al.
Published: (2021-05-01)

Disseminated cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in human immunodeficiency virus (HIV)-infected patients: A report of two cases
by: Camila F Araujo, et al.
Published: (2021-01-01)

Natural canine infection by Leishmania infantum and Leishmania amazonensis and their implications for disease control
by: Letícia da Cruz Sanches, et al.

Cutaneous Leishmaniasis Caused by an Unknown Leishmania Strain, Arizona, USA
by: Marcos de Almeida, et al.
Published: (2021-06-01)

Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis
by: Fernando T Silveira, et al.
Published: (2005-08-01)

Leishmania life cycle images in the cutaneous cytologic smear of an immunocompetent patient
by: Zappacosta Roberta, et al.
Published: (2010-01-01)

Effects of Brazilian propolis on Leishmania amazonensis
by: Diana Copi Ayres, et al.
Published: (2007-03-01)

Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+-epitopes of Leishmania donovani Nucleoside Hydrolase terminal domains
by: Dirlei eNico, et al.
Published: (2014-05-01)

Efficacy of the treatment using a microemulsion loaded with epoxy-α-lapachone in combination with meglumine antimoniate against murine infection by Leishmania (Leishmania) amazonensis
by: Juliana Figueiredo Peixoto, et al.
Published: (2024-04-01)

Cutaneous sporotrichoid leishmaniasis: An atypical case caused by Leishmania major
by: Adila Bassaid, et al.
Published: (2022-01-01)

Impact of leishmaniasis on public health
by: L. B Camargo, et al.
Published: (2006-01-01)

Reacción de antígenos de Leishmania (Leishmania) mexicana con sueros de pacientes con leishmaniosis cutánea de Sinaloa, México Reaction of Leishmania (Leishmania) mexicana antigens by sera of patients with cutaneous leishmaniasis from Sinaloa, Mexico
by: Patricia Guadalupe Salazar-Mejía, et al.
Published: (2010-04-01)

Disseminated Leishmaniasis, a Severe Form of Leishmania Braziliensis Infection
by: Paulo R.L. Machado, et al.
Published: (2024-03-01)

Cutaneous Leishmania mexicana infections in the United States: defining strains through endemic human pediatric cases in northern Texas
by: Binita Nepal, et al.
Published: (2024-03-01)

Comparison of the specificity of PCR and the histopathological detection of leishmania for the diagnosis of American cutaneous leishmaniasis
by: A.C.R. Medeiros, et al.
Published: (2002-04-01)

Active cutaneous leishmaniasis in Brazil, induced by Leishmania donovani chagasi
by: M. P. Oliveira Neto, et al.
Published: (1986-09-01)

Outbreak of cutaneous leishmaniasis in the Rio Doce Valley, Minas Gerais, Brazil
by: Marco Victor Hermeto, et al.
Published: (1994-12-01)

Efficacy of a diarylheptanoid derivative against Leishmania amazonensis
by: Alves Luciana Vignólio, et al.
Published: (2003-01-01)

The Role of Phosphoglycans in the Susceptibility of Leishmania mexicana to the Temporin Family of Anti-Microbial Peptides
by: Gabriela A. Eggimann, et al.
Published: (2015-02-01)

Interleukin-4 Receptor Alpha: From Innate to Adaptive Immunity in Murine Models of Cutaneous Leishmaniasis
by: Ramona Hurdayal, et al.
Published: (2017-11-01)

O uso da associação azitromicina e N-metil glucamina no tratamento da leishmaniose cutânea causada por Leishmania (Leishmania) amazonensis em camundongos C57BL6 The use of azythromycin and N-methyl glucamine for the treatment of cutaneous Leishmaniasis caused by Leishmania (Leishmania) amazonensis in C57BL6 mice
by: Raimunda Nonata Ribeiro Sampaio, et al.
Published: (2009-04-01)

A Rare Case of Imported Cutaneous Leishmaniasis Caused by <i>Leishmania infantum</i> in the Republic of Korea, 2021
by: Hyun Jung Kim, et al.
Published: (2023-04-01)

Imported cutaneous leishmaniasis caused by Leishmania major in a Chinese laborer who worked in Saudi Arabia
by: Min Zhang, et al.
Published: (2016-06-01)

Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major induced Cutaneous Leishmaniasis
by: A Khamesipour, et al.
Published: (2012-06-01)